Benjamin Haynor

John McAulay

Michael Freeman

Scott McAuley

Rahul Sarugaser

Brian Gagnon

Frederick Wise

Michael Sarcone

- **Profound Medical Corp.** anticipates preliminary unaudited total revenues for the third quarter of 2025 to be in the range of **$5.2 million to $5.3 million**.  **[1628808_0001171843-25-006317_exh_991.htm:0]** 
- This represents a significant revenue growth of between **84% and 87%** compared to **$2.8 million** in the same period last year.  **[1628808_0001171843-25-006317_exh_991.htm:0]** 
- The company expects a gross margin of approximately **72%** for Q3 2025, an increase from **64%** in the prior year period.  **[1628808_0001171843-25-006317_exh_991.htm:0]** 
- The TULSA-PRO® installed base has grown to **67** systems, up from 60, with a target of at least **75** by the end of the year.  **[1628808_0001171843-25-006317_exh_991.htm:0]** 
- Full third quarter 2025 financial results are scheduled to be released on **November 13, 2025**.  **[1628808_0001171843-25-006317_exh_991.htm:0]**

Profound Medical announces record preliminary Q3 2025 revenue

- Profound Medical Corp. anticipates preliminary unaudited total revenues for the third quarter of 2025 to be in the approximate range of **$5.2 million to $5.3 million**.  **[1628808_4687a572c880497a9441be4ef0a92a9d_0]** 
- This represents a revenue growth of between **84% and 87%** over **$2.8 million** reported in the same period a year ago.  **[1628808_4687a572c880497a9441be4ef0a92a9d_0]** 
- Gross margin for Q3 2025 is expected to be approximately **72%**, an increase from **64%** in the prior year period.  **[1628808_4687a572c880497a9441be4ef0a92a9d_0]** 
- The TULSA-PRO® installed base grew to **67** from 60, with the company expecting to reach at least **75** by the end of the year.  **[1628808_4687a572c880497a9441be4ef0a92a9d_0]** 
- The company plans to announce its full third quarter 2025 financial results on Thursday, **November 13, 2025**.  **[1628808_4687a572c880497a9441be4ef0a92a9d_0]**

Profound Medical Announces Preliminary Unaudited Q3 2025 Revenue

Profound Medical (PROF)